Therefore, GCs, by activating GR signaling, may control tumor growth (1) indirectly through modulation of immune system and cells in the tumor microenvironment, or (2) directly by controlling cancer cell survival pathways and affecting tumor cell biology (Fig. 1). Here, NR3C1 is linked to cancer.